Yanmei Lu

7.6k total citations · 1 hit paper
39 papers, 3.0k citations indexed

About

Yanmei Lu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Yanmei Lu has authored 39 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Oncology. Recurrent topics in Yanmei Lu's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (8 papers) and Protein purification and stability (4 papers). Yanmei Lu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (8 papers) and Protein purification and stability (4 papers). Yanmei Lu collaborates with scholars based in United States, China and France. Yanmei Lu's co-authors include Ryan J. Watts, Wilman Luk, Kwame Hoyte, Mark S. Dennis, Jasvinder K. Atwal, Saileta Prabhu, Nga Bien‐Ly, Yin Zhang, J. Michael Elliott and Margaret Kenrick and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and The Journal of Experimental Medicine.

In The Last Decade

Yanmei Lu

36 papers receiving 2.9k citations

Hit Papers

Boosting Brain Uptake of a Therapeutic Antibody by Reduci... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers

Yanmei Lu
Kwame Hoyte United States
Wilman Luk United States
Irina V. Balyasnikova United States
S. Patricia Becerra United States
Simone P. Niclou Luxembourg
Achim Temme Germany
Ken Aldape United States
Yanmei Lu
Citations per year, relative to Yanmei Lu Yanmei Lu (= 1×) peers Arsalan S. Haqqani

Countries citing papers authored by Yanmei Lu

Since Specialization
Citations

This map shows the geographic impact of Yanmei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanmei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanmei Lu more than expected).

Fields of papers citing papers by Yanmei Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanmei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanmei Lu. The network helps show where Yanmei Lu may publish in the future.

Co-authorship network of co-authors of Yanmei Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanmei Lu. A scholar is included among the top collaborators of Yanmei Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanmei Lu. Yanmei Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schreeb, Katharina, Claire Chapman, Yanmei Lu, et al.. (2025). STEADFAST Study Update: A Phase 1/2 Clinical Trial of Regulatory T Cells Expressing a Chimeric Antigen Receptor Directed Towards HLA-A2 in Renal Transplantation. American Journal of Transplantation. 25(8). S265–S265.
2.
Cao, Zipeng, Yanmei Lu, Qiang Yang, et al.. (2025). Mapping the hidden journey of microplastics: Multi-organ deposition patterns and organ-specific health risks revealed by AI-driven analysis. The Innovation. 7(1). 101031–101031.
4.
Liu, Jiayue, Yanmei Lu, Yufang Hu, et al.. (2024). Portable Detection of Lysine Acetyltransferase Activity in Lung Cancer Cells Based on a Miniature Electrochemical Sensor. Analytical Chemistry. 96(14). 5546–5553. 4 indexed citations
5.
Hu, Dandan, Di Wu, Yanmei Lu, et al.. (2022). Protonation-induced DNA conformational-change dominated electrochemical platform for glucose oxidase and urease analysis. Analytica Chimica Acta. 1226. 340164–340164. 3 indexed citations
6.
Ledeboer, Annemarie, et al.. (2022). Clinical enrollment assay to detect preexisting neutralizing antibodies to AAV6 with demonstrated transgene expression in gene therapy trials. Gene Therapy. 30(1-2). 150–159. 18 indexed citations
7.
Bien‐Ly, Nga, C. Andrew Boswell, Surinder Jeet, et al.. (2015). Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies. Neuron. 88(2). 289–297. 150 indexed citations
8.
Zuchero, Y. Joy Yu, Xiaocheng Chen, Nga Bien‐Ly, et al.. (2015). Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies. Neuron. 89(1). 70–82. 197 indexed citations
9.
Bien‐Ly, Nga, Yang Yu, Daniela Bumbaca, et al.. (2014). Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants. The Journal of Experimental Medicine. 211(2). 233–244. 244 indexed citations
10.
Liu, Yinglong, et al.. (2014). The complete mitochondrial genome of theAcrossocheilus fasciatus(Cyprinidae, Barbinae). Mitochondrial DNA. 26(6). 941–942. 3 indexed citations
11.
Deng, Rong, Y. Gloria Meng, Kwame Hoyte, et al.. (2012). Subcutaneous bioavailability of therapeutic antibodies as a function 
of FcRn binding affinity in mice. mAbs. 4(1). 101–109. 66 indexed citations
12.
Yan, Xin, Shuang Bai, Lisa A. Damico‐Beyer, et al.. (2012). Anti-Neuropilin-1 (MNRP1685A): Unexpected Pharmacokinetic Differences Across Species, from Preclinical Models to Humans. Pharmaceutical Research. 29(9). 2512–2521. 25 indexed citations
13.
Jackman, Janet, Yongmei Chen, Arthur Huang, et al.. (2010). Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling. Journal of Biological Chemistry. 285(27). 20850–20859. 68 indexed citations
14.
Junttila, Teemu T., Kathryn L. Parsons, Christine Olsson, et al.. (2010). Superior In vivo Efficacy of Afucosylated Trastuzumab in the Treatment of HER2-Amplified Breast Cancer. Cancer Research. 70(11). 4481–4489. 179 indexed citations
15.
Lu, Yanmei, Hong Xiang, Peter Liu, et al.. (2009). Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration. mAbs. 1(4). 364–369. 34 indexed citations
16.
Lu, Yanmei, Wai Lee Wong, & Y. Gloria Meng. (2006). A high throughput electrochemiluminescent cell-binding assay for therapeutic anti-CD20 antibody selection. Journal of Immunological Methods. 314(1-2). 74–79. 18 indexed citations
17.
Gong, Qian, Qinglin Ou, Shiming Ye, et al.. (2005). Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy. The Journal of Immunology. 174(2). 817–826. 423 indexed citations
18.
Hong, Kyu, Leonard G. Presta, Yanmei Lu, et al.. (2004). Simple quantitative live cell and anti-idiotypic antibody based ELISA for humanized antibody directed to cell surface protein CD20. Journal of Immunological Methods. 294(1-2). 189–197. 22 indexed citations
19.
Hossain, Ferdaus, et al.. (2004). Genetically Modified Cotton and Farmers' Health in China. International Journal of Occupational and Environmental Health. 10(3). 296–303. 83 indexed citations
20.
Lu, Yanmei, Jennifer Brush, & Timothy A. Stewart. (1999). NSP1 Defines a Novel Family of Adaptor Proteins Linking Integrin and Tyrosine Kinase Receptors to the c-Jun N-terminal Kinase/Stress-activated Protein Kinase Signaling Pathway. Journal of Biological Chemistry. 274(15). 10047–10052. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026